Skip to main content

Advertisement

Table 5 Treatment regimens for all 13 patients with npAIR with time of symptom onset to initiation of treatments

From: Non-paraneoplastic autoimmune retinopathy: multimodal testing characteristics of 13 cases

Patient Affected eye Treatment Time from symptom onset to treatment
1 OU Observation n/a
2 OS Observation n/a
3 OS Mycophenolate mofetil 500 mg BID, switched to azathioprine 200 mg 7 years
4 OU Observation n/a
5 OU Valacyclovir 3 g daily 1 week, 1 g daily 21 days 2 years
6 OD Beta carotene 25,000 IU, vitamin E 400 IU, lutein 20 mg, CoQ10 300 mg BID, mycophenolate mofetil 1000 mg BID 9 years
7 OS Observation n/a
8 OS Observation n/a
9 OU Observation n/a
10 OS Mycophenolate mofetil 500 mg 6 years
11 OD Observation n/a
12 OD Observation n/a
13 OU Rituximab (2 doses, 1 g), IV methylprednisolone (2 doses) followed by oral prednisone taper 41 years